Indeed, among the several cell cycle‐related proteins investigated, CyclinB1 and CDK1 were noticeably decreased upon VLX1570 treatment in a dose‐dependent manner in lung cancer cells (Figure 3C). The gene discussed is CDK1; the disease is lung cancer.